1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (1694)
  2. Journal Article (1416)
  3. Review (80)
  4. Editorial (56)
  5. Book Section (35)
  6. Guidelines (24)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3351)
  2. Solid Tumor Oncology Division (3351)
  3. Thoracic Oncology (3351)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Human Oncology and Pathogenesis Program (625)

More Groups

People
  1. Mark Kris (869)
  2. Alexander Drilon (631)
  3. Gregory Riely (599)
  4. Charles Rudin (488)
  5. Marc Ladanyi (414)
  6. Matthew Hellmann (411)

More People

Years
  1. 2025 (73)
  2. 2024 (270)
  3. 2023 (272)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (692)
  2. Journal of Thoracic Oncology (513)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (156)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (769)
  2. Elsevier Inc. (734)
  3. American Association for Cancer Research (383)
  4. Oxford University Press (350)
  5. Nature Publishing Group (148)
  6. Elsevier Science, Inc. (78)

More Publishers

Results (3351)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term efficacy and genomic characteristics of patients with TRK fusion lung cancer treated with larotrectinib
    Meeting Abstract

    Moreno Garcia, V.; Lin, J.; Patel, J.; Lassen, U.; Solomon, B.; Rosen, L.; Leyvraz, S.; Tan, D. S. W.; Reeves, J. A.; Beckmann, G.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • A phase 2 trial of MRTX849 in combination with pembrolizumab in patients with advanced non-small cell lung cancer with KRAS G12C mutation
    Meeting Abstract

    Spira, A.; Riely, G.; Lawler, W.; Shum, M.; Socinski, M.; Yanagihara, R.; Roshan, S.; Kheoh, T.; Christensen, J.; Chao, R.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Phase I study of AMG 757, a delta-like ligand 3 (DLL3) targeting, half-life extended bispecific T-cell engager immuno-oncology therapy, in small cell lung cancer (SCLC)
    Meeting Abstract

    Paz-Ares, L.; Owonikoko, T. K.; Johnson, M.; Govindan, R.; Izumi, H.; Lai, V.; Borghaei, H.; Boyer, M.; Boosman, R. J.; Hummel, H. D.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • MERMAID-2: Phase III study of durvalumab in patients with resected, stage II-III NSCLC who become MRD+ after curative-intent therapy
    Meeting Abstract

    Spigel, D. R.; Peters, S.; Ahn, M. J.; Tsuboi, M.; Chaft, J.; Harpole, D.; Barlesi, F.; Abbosh, C.; Mann, H.; May, R.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Phase 2 study of zenocutuzumab (MCLA-128), a bispecific HER2/HER3 antibody in NRG1 fusion-positive advanced solid tumors
    Meeting Abstract

    Schram, A.; Macarulla, T.; O'Reilly, E.; Rodon, J.; Wolpin, B.; Ou, S.; Kim, D.; Yang, J. C.; Lam, J.; De Langen, A.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Activity of tepotinib in brain metastases (BM): Preclinical and clinical data in MET exon 14 (METex14) skipping NSCLC
    Meeting Abstract

    Mazieres, J.; Veillon, R.; Felip, E.; Le, X.; Garassino, M. C.; Stanton, T.; Morise, M.; Lee, J.; Matsumoto, S.; De Marinis, F.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Delta-radiomics features for assessment of individualized therapeutic response in small cell lung cancer - A pilot study
    Meeting Abstract

    Araujo Filho, J.; Murciano-Goroff, Y.; Gibbs, P.; Perez-Johnston, R.; Lai, W. V.; Rudin, C.; Li, B.; Ginsberg, M.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • ORCHARD: A biomarker-directed phase 2 platform study in pts with advanced EGFRm NSCLC progressing on first-line osimertinib
    Meeting Abstract

    Cho, B. C.; Piotrowska, Z.; Le, X.; Goldberg, S. B.; Goldman, J.; De Langen, A.; Okamoto, I.; Smith, P.; Mensi, I.; Maidment, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • CD8α-enhanced NY-ESO-1-specific TCR T Cells (GSK3901961) in HLA-A*02 patients with NSCLC: Master protocol substudy 1
    Meeting Abstract

    Altan, M.; Govindan, R.; Schoenfeld, A.; Noujaim, J.; Sacher, A.; Haanen, J.; Huang, C.; Hasan, A.; Faitg, T.; Butler, E.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Diminished efficacy of PD-(L)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma is impacted by KRAS mutation status
    Meeting Abstract

    Ricciuti, B.; Arbour, K.; Lin, J.; Vajdi, A.; Tolstorukov, M.; Hong, L.; Zhang, J.; Vokes, N.; Li, Y.; Spurr, L.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save